The Stem Cells and Immunotherapy course (STI-1103) of the Advanced Stem Cell Education Program is designed to enhance the knowledge of healthcare professionals on current clinical hematopoietic stem cell therapies to treat both genetic and acquired diseases.
Hematopoietic stem cells are derived from mesoderm and give rise to all the other blood cells. They are usually extracted from bone marrow, peripheral blood, or umbilical cord blood. Hematopoietic stem cell transplantation involves the intravenous infusion of autologous or allogeneic stem cells to reestablish hematopoietic function in patients whose bone marrow or immune system is damaged or defective. Hematopoietic stem cell transplantations are often performed to eliminate a bone marrow infiltrative process, such as leukemia, or to correct congenital immunodeficiency disorders. Hematopoietic stem cell transplantation allows patients with cancer to receive higher doses of chemotherapy than the bone marrow can usually tolerate; bone marrow function is then salvaged by replacing the marrow with previously harvested stem cells.
• This is a subspeciality course with a cost of $2500.
• Self-paced open enrollment
• Physician CME Eligible: Yes: 33.5 CME AMA PRA Category 1 Credits™
• Program includes digital streaming of lectures and PDF resources
• Learn instantly with any computer or laptop with a strong internet connection
• Estimated effort: 6-7 weeks of material, 4-5 hours/week; 5 topic quizzes, final exam
Some background in biology is helpful.
• Biology Of Stem Cells
• Regulation of Stem Cell Therapies